Agile Therapeutics, Inc. (AGRX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Show:
Annual
Income Statement
All numbers in thousandsBreakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
4,101
4,101
749
0
0
Cost of Revenue
10,718
10,718
282
-
-
Gross Profit
-6,617
-6,617
467
-
-
Operating Expenses
Research Development
6,246
6,246
13,500
9,858
9,777
Selling General and Administrative
58,142
58,142
36,020
9,000
8,739
Total Operating Expenses
64,388
64,388
49,520
18,858
18,516
Operating Income or Loss
-71,005
-71,005
-49,053
-18,858
-18,516
Interest Expense
3,914
3,914
3,109
0
1,116
Total Other Income/Expenses Net
-
-
-
-
-990
Income Before Tax
-74,894
-74,894
-51,853
-18,606
-20,256
Income Tax Expense
-
-
0
0
-477
Income from Continuing Operations
-74,894
-74,894
-51,853
-18,606
-19,779
Net Income
-74,894
-74,894
-51,853
-18,606
-19,779
Net Income available to common shareholders
-74,894
-74,894
-51,853
-18,606
-19,779
Basic EPS
-
-
-24.40
-15.20
-23.20
Diluted EPS
-
-
-24.40
-15.20
-23.20
Basic Average Shares
-
-
2,117
1,236
857.898
Diluted Average Shares
-
-
2,117
1,236
857.898
EBITDA
-
-68,757
-48,468
-18,443
-19,117
